论文部分内容阅读
目的:观察克林霉素对治疗急性下呼吸道感染的有效性。方法:选取我院2010年至2011年接收的急性下呼吸道感染患者52例为观察对象。患者经检查确诊为急性下呼吸道感染后,接受克林霉素静脉滴注,观察用药的有效率和不良反应发生率。结果:30例痊愈,16例显效,总有效率为88.46%,细菌清除率为90.48%,不良反应发生率为5.77%。结论:克林霉素对急性下呼吸道感染的治疗效果较为显著,且不良反应少,是一种相对安全的治疗药物。
Objective: To observe the effectiveness of clindamycin in the treatment of acute lower respiratory tract infection. Methods: 52 cases of acute lower respiratory tract infection received in our hospital from 2010 to 2011 were selected as the observation subjects. Patients diagnosed as acute lower respiratory tract infection, receiving clindamycin intravenous infusion, observe the effectiveness of the drug and the incidence of adverse reactions. Results: 30 cases recovered, 16 cases markedly effective, the total effective rate was 88.46%, the bacterial clearance rate was 90.48%, the incidence of adverse reactions was 5.77%. Conclusion: Clindamycin is more effective in treating acute lower respiratory tract infection with less adverse reactions, which is a relatively safe therapeutic drug.